Literature DB >> 27663437

Portal vein thrombus and infiltrative HCC: a pictoral review.

Christopher P Sereni1, Shuchi K Rodgers2, Cheryl L Kirby2, Igor Goykhman2.   

Abstract

Infiltrative hepatocellular carcinoma (HCC) can be overlooked on imaging. Radiologists should have a high index of suspicion for this entity in patients with chronic liver disease. Careful evaluation of the portal vein may help the radiologist diagnose infiltrative HCC, due to the high association (68%-100%) of portal vein tumor thrombus with this condition. This article will review the imaging findings of infiltrative HCC, particularly its association with portal vein thrombus, and describe imaging pitfalls and mimickers.

Entities:  

Keywords:  Cirrhosis; Infiltrative hepatocellular carcinoma; Portal vein thrombus; Tumor thrombus

Mesh:

Year:  2017        PMID: 27663437     DOI: 10.1007/s00261-016-0855-z

Source DB:  PubMed          Journal:  Abdom Radiol (NY)


  4 in total

1.  Sub-classification of Advanced-Stage Hepatocellular Carcinoma: A Cohort Study Including 612 Patients Treated with Sorafenib.

Authors:  Jeong-Ju Yoo; Goh Eun Chung; Jeong-Hoon Lee; Joon Yeul Nam; Young Chang; Jeong Min Lee; Dong Ho Lee; Hwi Young Kim; Eun Ju Cho; Su Jong Yu; Yoon Jun Kim; Jung-Hwan Yoon
Journal:  Cancer Res Treat       Date:  2017-05-15       Impact factor: 4.679

2.  The long non-coding RNA Linc-GALH promotes hepatocellular carcinoma metastasis via epigenetically regulating Gankyrin.

Authors:  Xiaoliang Xu; Yun Lou; Junwei Tang; Yue Teng; Zechuan Zhang; Yin Yin; Han Zhuo; Zhongming Tan
Journal:  Cell Death Dis       Date:  2019-01-28       Impact factor: 8.469

3.  Infiltrative non-mass-like hepatocellular carcinoma initially presenting with isolated malignant portal vein thrombosis: A case report and review of the literature.

Authors:  Anıl Çolaklar; Namık Kemal Altınbaş
Journal:  J Ultrason       Date:  2020-03-31

4.  Infiltrative Hepatocellular Carcinoma: Transcatheter Arterial Chemoembolization Versus Hepatic Arterial Infusion Chemotherapy.

Authors:  Chao An; Mengxuan Zuo; Wang Li; Qifeng Chen; Peihong Wu
Journal:  Front Oncol       Date:  2021-12-16       Impact factor: 6.244

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.